Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 1, 2019.
Article Versions
- You are currently viewing a Latest version of this article (March 1, 2019 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2019 The Journal of Rheumatology
Author Information
- Hasan Gökcer Tekin,
- Jashin J. Wu,
- Russel Burge,
- Julie Birt and
- Alexander Egeberg
- From the Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark; Kaiser Permanente Los Angeles Medical Center, Department of Dermatology, Los Angeles, California; Eli Lilly and Co., Indianapolis, Indiana; Division of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, Ohio, USA.
This study was funded by Eli Lilly and Co. The funding source participated in interpretation of the final analyzed study results, but had no access to the raw data, and did not participate in data collection, management, or analysis. Dr. Wu is an investigator for AbbVie, Amgen, Eli Lilly, Janssen, Novartis, and Regeneron. Dr. Burge and J. Birt are currently employed by Eli Lilly and Co. Dr. Egeberg has received research funding from Pfizer, Eli Lilly, the Danish National Psoriasis Foundation, and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as a consultant and/or speaker from Leo Pharma, Samsung Bioepis Co. Ltd., Pfizer, Eli Lilly, Novartis, Galderma, and Janssen Pharmaceuticals.
H.G. Tekin, MD, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen; J.J. Wu, MD, Kaiser Permanente Los Angeles Medical Center, Department of Dermatology; R. Burge, PhD, Eli Lilly and Co., and Division of Pharmaceutical Sciences, University of Cincinnati; J. Birt, PharmD, Eli Lilly and Co.; A. Egeberg, MD, PhD, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen.
Address correspondence to Dr. A. Egeberg, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Kildegårdsvej 28, 2900 Hellerup, Denmark. E-mail: alexander.egeberg@gmail.com.
Accepted for publication October 23, 2018.